正常与癌症肺组织的傅里叶变换红外光谱差异的研究

傅里叶变换红外(FTIR)光谱可以在分子水平上研究细胞和组织等复杂的生命体系,提供分子结构和组成的信息.我们发展了一种用于直接测定肿瘤及正常组织红外光谱的方法,对16例肺癌及其癌旁正常组织进行了测定.结果表明,对于正常和癌变的肺组织,FTIR光谱中存在显著差异,相关谱带的相对峰高比可以表征这些差异.因此,傅里叶变换红外光谱可以用来诊断癌症与正常的肺组织,有望成为肿瘤快速诊断的新方法.     

女性乳腺肿瘤的傅里叶变换红外光谱鉴别方法的探索

通过75例女性良,恶性乳腺肿瘤及正常乳腺组织的傅里叶变换红外光谱(FTIR)对比研究发现,它们之间存在着明显而规律的光谱差异,这反 映了组织中蛋白质,核酸和脂类等生物分子在不同性质的乳腺肿瘤中的构型与构像及以及相对含量上的差别,研究表明,FTIR可从分子水平上揭示肿瘤组织的特性,能对良,恶性乳腺肿瘤的鉴别提供丰富而可靠的结构信息,极有可能发展成为一种肿瘤鉴别方法.     

傅里叶变换红外光谱体表无创探测乳腺肿瘤

利用傅里叶变换红外(FTIR)光谱仪联合衰减全反射(ATR)探头的中红外光导纤维对46名健康志愿者及113名乳腺肿物患者的体表皮肤进行无创红外光谱测定, 并从分子水平比较、分析了正常乳腺和有肿物乳腺体表皮肤的红外光谱特征. 结果表明, 健康志愿者乳房皮肤8个FTIR光谱测定部位的图谱趋于一致; 正常乳腺体表与有肿瘤乳腺体表的吸收峰差异明显, 而1080 cm^-1处核酸相关吸收峰的变化对鉴别肿瘤的良、 恶性有重要意义.     

人体乳腺癌组织红外光谱特征的研究

利用红外光谱法对正常乳腺组织、良性肿瘤和乳腺癌组织进行了对比研究.与正常组织的光谱相比,癌组织中蛋白质的某些氨基酸残基的ν_C-O(H)谱带位置明显向高波数位移,表明组织中该基团中的氢键大部分被破坏.蛋白质分子的氢键化的ν_NH谱带位置向低波数位移,且谱带形状也有所改变,说明NH…O=C氢键化程度增强.核酸的磷酸二酯基团的ν_s,PO₂^-谱带吸收强度明显增强,反映癌细胞内DNA相对含量增加;位于970cm^-1附近的ν_s,PO₃^{-谱带强度增加,提示细胞中磷酸化蛋白含量增加.而胶原蛋白的特征谱带强度减弱,说明其相对含量减少.研究证明,红外光谱可在分子水平上揭示乳腺肿瘤的特征.}     

傅里叶变换中红外光谱技术用于人体胃镜样品检测的新方法

应用傅里叶变换红外光谱(FTIR)测定了184例胃镜样品,总结不同病变类型组织的光谱特征,并与病理结果进行比较.实验结果表明,由于不同类型病变组织会在其分子组成和结构上发生相应改变,浅表性胃炎、萎缩性胃炎和胃癌组织具有不同的FTIR光谱,可据此进行胃镜样品疾病类型和病变程度的判别.研究结果表明,FTIR技术有望发展成为一种用于胃镜样品无创、快速、准确的在体临床诊断的新方法.     

甲状腺癌微转移淋巴结的红外光谱检测

采用衰减全反射(ATR)探头和傅里叶变换红外光谱(FTIR)仪测定了新鲜离体的甲状腺癌微转移颈部淋巴结(16枚)和非转移性淋巴结(16枚)的FTIR光谱, 配对比较了两组光谱13个谱带的峰位、相对峰强及半高宽等38个FTIR参数, 明确了甲状腺癌微转移淋巴结的光谱特征.结果表明, 与非转移性淋巴结相比, 微转移淋巴结光谱中与蛋白、脂质、糖类和核酸相关的谱带均发生了明显变化:与蛋白质相关的谱带的相对峰强I₃₂₈₀/I₁₄₆₀和I₁₆₄₀/I₁₄₆₀显著升高, 半高宽F₁₆₄₀显著增宽, 而F₁₅₄₆则变窄; 与脂类相关的相对峰强I₁₄₀₀/I₁₄₆₀明显增高; 与糖类相关的1165 cm^-1处谱带的相对峰强I₁₁₆₅/I₁₄₆₀显著降低; 与核酸相关的1240 cm^-1处谱带的相对峰强I₁₂₄₀/I₁₄₆₀显著升高.结果表明, FTIR能够检测出甲状腺癌的微转移淋巴结, 可能应用于甲状腺癌病人的精准手术治疗.     

38例乳腺肿块超声诊断分析

为分析探讨乳腺肿块的高频超声图像特点，提高超声对乳腺肿块的诊断与鉴别水平，利用高频超声探头（７．５￣１０ＭＨｚ）对３８例有手术及病理证实的乳腺肿块进行了诊断，并与病理结果进行对比研究，其中包括有乳腺小叶增生４例，纤维瘤５例，恶性肿瘤１９例。     

新鲜乳腺癌组织的近红外拉曼光谱分析

采用便携式拉曼光谱仪对正常、良性和恶性的乳腺癌组织进行检测,通过对其拉曼光谱的指认,归纳了其主要区别和特征. 在3类乳腺组织中有明显的脂类的特征峰（1230,1268,1301,1440和1743 cm^-1）,而在良性和恶性的组织中,则出现了较为明显的蛋白（1246,1271,1315和1364 cm^-1）和核酸（1340 cm^-1）的特征峰. 良性和恶性组织的区别在于恶性组织特有的特征峰（1340 cm^-1）,而良性组织所特有的特征峰则应归属为蛋白. 在数据分析过程中,选择能够反映样本化学本质的特征峰,利用高斯过程的机器学习对特征峰值建立模型. 特异性（0.94）、灵敏度（0.95）和Matthews相关系数（0.86）表明在模型中3种组织有比较良好的辨别度,对于应用拉曼光谱方法辨别正常和患病乳腺组织具有参考价值.     

尼龙1010红外光谱的研究

本文研究了尼龙1010的红外光谱。观测了不同热处理样品的红外光谱变化和密度,并测定了拉伸样品的偏振红外光谱。应用因子群解析、简正振动类比,得到许多振动的对称类型、偏振光学性质及选律,进而对尼龙1010的红外光谱谱带做了初步归属,还用电子计算机分峰的方法得到一些新谱带,并就若干谱带展开了讨论.     

中红外光纤技术研究胃正常和肿瘤组织及其原位、在体临床应用

采用中红外光纤衰减全反射光谱法研究胃组织样品, 以48个病人的90个胃组织的红外光谱, 包括32个正常和58个肿瘤组织样品. 肿瘤光谱的特征通常表现在CH和C=O峰的消失, 酰胺I带以及接近1545 cm^−1的弱的酰胺II带向低波数位移, 1450 cm^−1峰强度下降并一般弱于1400 cm^−1峰. 减谱结果表明正常和肿瘤组织的酰胺I带和酰胺II带在峰位和相对强度方面有着较大的差别. 统计分析结果证实了这一结论. 结果表明中红外光纤技术提供了胃肿瘤组织的信息, 能够用来区分正常和肿瘤组织. 实现了肿瘤的在体原位检测, 在手术室旁对新鲜离体样品以及手术过程中在体原位检测恶性肿瘤的结果同对体外液氮冰冻样品和病理检测所得到的结论一致, 这一新结果成为临床应用的基础.     

傅里叶变换红外光谱法用于体表无创性检测乳腺肿瘤的研究

乳腺肿瘤是女性常见的疾病之一,其中乳腺癌的发病率在女性恶性肿瘤中占首位,并且发病率呈不断增加的趋势,严重危害妇女的身体健康．乳腺癌的早期诊断和治疗是提高乳腺癌患者整体生存率的关键．目前大多采用传统的X线、超声、CT和核磁共振等技术进行影像诊断,这些诊断方法需要等到肿块形成具有占位效应时才能检测出来．而振动光谱法是分子结构变化的灵敏探针,它在癌症形成的初级阶段即可观察到分子结构的改变,因此傅里叶变换中红外光谱技术有可能发展成为一种无损伤、快速和方便的肿瘤早期诊断方法．     

乳腺癌组织中蛋白质二级结构的Fourier变换红外光谱研究

根据乳腺大汗腺癌、小管癌、黏液癌、浸润导管癌、单纯癌和髓样癌组织Ｆｏｕｒｉｅｒ变换红外光谱酰胺Ⅰ带的去卷积和拟合分析,获得组织中蛋白质二级结构的数目及其组成。结果表明：这些组织中蛋白质二级结构的数目及其组成存在着显著的差异,并与组织的类型、分化、坏死等密切相关其中,髓样癌的差异性最大;高分化癌中螺旋结构的含量及非典型螺旋和α－螺旋含量的比值均比低分化癌的相应值高;肿瘤边缘坏死的乳腺癌组织也表现出明     

2,4-二(2-烯炳基苯氧基)-6-N,N-二甲(乙)基胺基-1,3,5-三嗪的直接一步法合成

近年来,以三聚氯氰为原料合成含烯丙基和均三嗪环的反应性单体的研究时有报道［１～３］．这类单体易于合成、储存稳定性好,可作为双马来酰亚胺的增韧改性剂,并且由于这类化合物分子结构中活性反应点较多,它们有望在药物、生物材料等领域找到新的用途．我们曾以水为反应介质合成了２,４,６三（２烯丙基苯氧基）１,３,５三嗪（ＴＡＰＴ）［４,５］．为获得对双马来酰亚胺有显著改性效果的系列品种,我们在保留三嗪环上有一定数量的烯丙基和芳香结构,以确保单体有一定反应性又保证其与双马来酰亚胺的共聚物有较好的耐热性的…     

Fourier transform infrared study of the effect of diabetes on rat liver and heart tissues in the CH region

Diabetes mellitus is characterized by hyperglycemia, a relative lack of insulin. The metabolic disturbances in diabetic patients are often associated with cardiac and liver dysfunctions. Generally, experimental diabetic models in animals have been used to study diabetes-related changes in organ function, but the complexity of intact tissues can cause contradictory results. For this reason, different techniques have been used to understand the mechanisms of these dysfunctions in diabetic organs. The purpose of the present study is to investigate the effects of streptozotocin (STZ)-induced diabetes on rat liver and heart tissues at the molecular level by Fourier Transform Infrared (FTIR) spectroscopy. Wistar rats of both sexes, weighing 200-250 g, were made diabetic by a single injection of 50 mg kg(-1) intraperitoneal (i.p.) streptozotocin dissolved in 0.05 M citrate buffer (pH 4.5) and they were kept for 4-5 weeks. The diabetes status was checked by measuring the blood glucose level. In the complex FTIR spectra, the bands in the CH region for example the CH(2) antisymmetric and symmetric stretching, the CH(3) symmetric and asymmetric stretching vibrations due to lipids and proteins in the 3000-2800 cm(-1) region and CH(2) scissoring around 1464 cm(-1) and the CH(3) scissoring at 1454 cm(-1) were analyzed. Characteristic spectral bands of these diabetic samples were compared with those of control group to confirm the effect of diabetes on liver and heart tissues. The FTIR spectra revealed dramatic differences in the band positions and bandwidths, signal intensity values and signal intensity ratios between diabetic and control tissues. Similar differences were observed for diabetic liver and heart tissues. A significant increase in the bandwidth of the CH(2) symmetric and antisymmetric stretching and the CH(3) symmetric and asymmetric stretching bands has been observed for both tissue types. The wavenumber of the CH(3) asymmetric stretching band shifts to lower values, indicating an increase in the order in the deep interior part of the lipid chains. The ratio of the CH(2) symmetric to CH(3) symmetric stretching band (lipid/protein ratio) decreases by 13% for diabetic heart and liver tissues. A decrease is also detected in the ratio of the CH(2) scissoring to the CH(3) scissoring mode. The overall intensity of these bands is seen to increase for diabetic tissues.     

Synthesis of the Biomimetic Polymer： Aliphatic Diamine and RGDS Modified Poly（d,l-lactic acid）

A novel poly（d, /-lactic acid） （PDLLA） based biomimetic polymer was synthesized by grafting maleic anhydride, butanediamine and arg-gly-asp-ser （RGDS） peptides onto the backbone of PDLLA, aiming to overcome the acidity and auto-accelerating degradation of PDLLA during degradation and to improve its biospecificity and biocompatibility. The synthetic copolymer was characterized by FTIR, ^13C NMR and amino acid analyzer （AAA）.     

Synthesis,experimental and DFT studies on crystal structure,FT-IR, 1H,and 13C NMR spectra,and evaluation of aromaticity of three derivatives of xanthens

Several derivatives of xanthenes are prepared by the condensation of aldehydes and dimedone in H₂O in the presence of a catalytic amount of trichlorotriazine. The crystalline products were characterized by FTIR, ¹H, and ¹³C NMR spectra. Density Functional Theory (DFT) calculations on the B3LYP level were used to optimize the geometry and calculate the crystal structure, FTIR, ¹H NMR and ¹³C NMR spectra of the selected synthesized compounds. We found that the values of FTIR, ¹H, and ¹³C NMR spectra obtained by the B3LYP method are in accordance with experimental data. The calculated NICS indicate that the six-membered rings in xanthenes are essentially homoaromatic.     

GC–MS method for the determination of paraben preservatives in the human breast cancerous tissue

The general presumption that the preservative laden personal care products may be one of the causative agents for breast cancer, has remained a matter of controversy during this decade. Extensive studies have not been carried out to either prove or disprove the role of preservatives in breast cancer incidences. In this study we have developed a new method for the identification and quantification of the preservatives such as methyl paraben (MeP), ethyl paraben (EtP), propyl paraben (PrP) and butyl paraben (BuP) in breast tissue using Gas Chromatography and Mass Spectrometry (GC–MS). Tissue was extracted by using acetone:n-hexane mixture (1:1 v/v) and derivatized with N-Methyl-N-(trimethylsilyl) trifluoroacetamide (MSTFA). The extent of reaction time and the amount of MSTFA to attain greater derivatization were optimized. The developed method yielded good recovery (mean ± SD) of 99.8 ± 5.1, 96 ± 4.4, 107 ± 17 and 113 ± 13% with relative standard deviations (RSDs) of 5.1, 4.6, 15.6 and 13%, and the limits of detection (LOD) of 2.02, 1.05, 1.71 and 3.75 ng g^{− 1} for MeP, EtP, PrP and BuP, respectively. The method was successfully validated for the determination of parabens including butyl paraben (log K_ow = 3.57) in cancerous breast tissues; this could be a promising one for screening of breast tissues and also the environment for paraben residues. As far as our knowledge goes this is the first GC–MS method for the determination of parabens in human tissue.     

Determination of siloxanes,silicon, and platinum in tissues of women with silicone gel-filled implants

Silicone [poly(dimethylsiloxane)] gel used in breast implants has been known to migrate through intact silicone elastomer shells, resulting in the clinically observable "gel bleed" on the implant surface. Although silicon concentrations in capsular tissues of women with silicone prostheses have been measured with element-specific silicon analyses, no silicone-specific investigation of these tissues has been performed as yet.A combination of element-specific inductively coupled plasma high-resolution isotope dilution mass spectrometry (ICP-HR-IDMS) and species-specific gas chromatography coupled mass spectrometry (GC-MS) was used to analyze silicon, platinum, and siloxanes in prosthesis capsule, muscle, and fat tissues of women (n=3) who had silicone gel-filled breast implants and in breast tissue of non-augmented women (n=3) as controls.In all tissues of augmented women, siloxanes, in particular octamethylcyclotetrasiloxane (D4), decamethylcyclopentasiloxane (D5), and dodecamethylcyclohexasiloxane (D6) were identified. Depending on the siloxane species and type of tissue analyzed, siloxane levels in the range of about 10-1,400 ng g(-1) were detected; total silicon was found in all tissue samples in the range of about 8,900-85,000 ng g(-1). Higher platinum levels ranging from 25-90 ng g(-1 )were detected in fibrin layer and fat tissue of two patients with prostheses. No siloxanes were detected in control breast tissue samples.This investigation of human tissues by a combination of element-specific and species-specific analytical techniques clearly demonstrates for the first time that platinum and siloxanes leak from prostheses and accumulate in their surrounding tissues.